Decibel Therapeutics, Inc. (DBTX) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 54 transactions totaling $75.9M, demonstrating a bullish sentiment with $75.7M in net insider flow. The most recent transaction on Sep 25, 2023 involved a transaction of 5,000 shares valued at $0.
No significant insider buying has been recorded for DBTX in the recent period.
No significant insider selling has been recorded for DBTX in the recent period.
Based on recent SEC filings, insider sentiment for DBTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $75.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Decibel Therapeutics, Inc. (DBTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading DBTX stock, having executed 54 transactions in the past 90 days. The most active insider is Peter A. Thompson (Executive), who has made 5 transactions totaling $30.0M.
Get notified when executives and directors at DBTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | Nochur Sara | Executive | Disposition | 5,000 | $N/A | $0 | |
| Sep 25, 2023 | C. Kapusta Matthew | Executive | Disposition | 10,000 | $N/A | $0 | |
| Sep 25, 2023 | Reid Laurence | Executive | Disposition | 220,849 | $N/A | $0 | |
| Sep 25, 2023 | F. Mclaughlin Kevin | Executive | Disposition | 5,000 | $N/A | $0 | |
| Sep 25, 2023 | Cecily Finger Alison | Executive | Disposition | 5,000 | $N/A | $0 | |
| Sep 25, 2023 | Jui-jen Lee John | Executive | Disposition | 147,144 | $N/A | $0 | |
| Sep 25, 2023 | H. Carson William | Executive | Disposition | 5,000 | $N/A | $0 | |
| Sep 25, 2023 | Trask Anna | Executive | Disposition | 106,864 | $N/A | $0 | |
| Jun 13, 2023 | F. Mclaughlin Kevin | Executive | Award | 5,000 | $N/A | $0 | |
| Jun 13, 2023 | Cecily Finger Alison | Executive | Award | 5,000 | $N/A | $0 | |
| Jun 13, 2023 | H. Carson William | Executive | Award | 5,000 | $N/A | $0 | |
| Jun 13, 2023 | Nochur Sara | Executive | Award | 5,000 | $N/A | $0 | |
| Mar 19, 2023 | C. Kapusta Matthew | Executive | Award | 10,000 | $N/A | $0 | |
| Mar 16, 2023 | Reid Laurence | Executive | Award | 195,000 | $N/A | $0 | |
| Jan 26, 2023 | Jui-jen Lee John | Executive | Award | 120,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 8 | $75.8M | 99.8% |
Sale(S) | 7 | $120.1K | 0.2% |
Disposition(D) | 8 | $0 | 0.0% |
Award(A) | 8 | $0 | 0.0% |
Conversion(C) | 23 | $0 | 0.0% |
Insiders at Decibel Therapeutics, Inc. are accumulating shares at an accelerated pace. With 20 insiders making 54 transactions totaling $75.8M in purchases versus $120.1K in sales, the net buying activity of $75.7M signals strong executive confidence. Peter A. Thompson (Executive) leads the buying activity with $30.0M in transactions across all time.